Lexeo Therapeutics, Inc LXEO IPO will take place November, 03 on the NASDAQ exchange under the ticker LXEO.
The company is offering shares at an expected price between $13.00 and $15.00 per share with an insider lock-up period of 180 days ending on May 01, 2024.
See also: Benzinga IPO Calendar
About Lexeo Therapeutics, Inc
Lexeo Therapeutics, Inc is a clinical stage genetic medicine company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated.
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
